1 Virchow R. Ueber die actue entzundng der arterian. Virchows Arch. 1847;1:272–378.
2 Laohapensang K, Rutherford B, Arworn S. Infected aneurysm. Ann Vasc Dis. 2010;3(1):16–23.
3 Okamoto T, Akaike T, Suga M, Tanase S, Horie H, Miyajima S, et al. Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem. 1997;272:6059–66.
4 Turjman AS, Turjman F, Edelman ER. Role of fluid dynamics and inflammation in intracranial aneurysm formation. Circulation. 2014;129:373–82.
5 Stengel A, Wolferth CC. Mycotic (bacterial) aneurysms of intravascular origin. Arch Intern Med (Chic). 1923;31:527–54.
6 Brown SL, Busuttil RW, Baker JD, Machleder HI, Moore WS, Barker WF. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg. 1984;1:541–7.
7 Deipolyi AR, Rho J, Khademhosseini A, Oklu R. Diagnosis and management of mycotic aneurysms. Clinical imaging. 2016;40(2):256–62.
8 Garb M. Appendicitis: an unusual cause of infected abdominal aortic aneurysm. Australas Radiol. 1994;38:68–9.
9 Oderich GS, Panneton JM, Bower TC, Cherry KJ, Rowland CM, Noel AA, et al. Infected aortic aneurysms, aggressive presentation, complicated early outcome, but durable results. J Vasc Surg. 2001;34:900–8.
10 Frazee JG, Cahan LD, Winter J. Bacterial intracranial aneurysms. J Neurosurg. 1980;53:633–41.
11 Carod Artal FJ. Clinical management of infectious cerebral vasculitides. Expert Review of Neurotherapeutics. 2016;16:2:205–21.
12 Matsuno Y, Fukumoto Y, Ishida N, Shimabukuro K, Takemura H. Mycotic left main coronary artery aneurysm following double-valve replacement for active infective endocarditis. Ann Thorac Cardiovasc Surg. 2013;19:70–2.
13 Baker DW, Whitehead NJ, Barlow M. Mycotic Coronary Aneurysms, Heart, Lung and Circulation 2020;29:128–36.
14 Clare CE, Barrow DL. Infectious intracranial aneurysms. Eurosurg Clin N Am. 1992;3:551–66.